Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

Accueil
Investir
Actions
Canadá
TSXV
Hemostemix Inc (HEM) Cours

Hemostemix Inc (HEM)

0,055

0,00

(0,00%)

Fermé 04 Juillet 10:00PM

Hemostemix Inc (HEM) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

0,055

( - )

Prix Achat

0,05

Prix Vente

0,055

Volume échangé

1 000

0,055 Fourchette du Jour 0,055

0,00 Plage de 52 semaines 0,00

Cap du marché

Clôture Veille

0,055

Ouverture

0,055

Dernière Transaction

Dernière heure de transaction

Volume financier

-

VWAP

-

Volume moyen (3 m)

$ 31 200

Actions en circulation

197 821 441

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-2,35

Bénéfice par action (BPA)

-0,02

Chiffre d'affairess (LTM)

-

Bénéfice net (LTM)

-4,22M

Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which completed Phase II clinical trial for the treatment of peripheral arterial disease, chronic limb t... Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which completed Phase II clinical trial for the treatment of peripheral arterial disease, chronic limb threatening ischemia, cardiovascular ischemia and angina, and vascular dementia. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada. Show more

Secteur

Healthcare

Industrie

Biotechnology & Life Sciences

Site Web

hemostemix.com

Siège social

Calgary, Canada

Fondé

-

Hemostemix Inc est coté dans le secteur Healthcare de la TSX Venture Exchange avec le ticker HEM. Le dernier cours de clôture d'Hemostemix était de $0,06. Au cours de la dernière année, les actions de Hemostemix ont été négociées dans une fourchette de prix de $ 0,00 à $ 0,00.

Hemostemix compte actuellement 197 821 441 actions en circulation. La capitalisation boursière d'Hemostemix est de $10,88 million. Hemostemix a un ratio cours/bénéfice (ratio PE) de -2.35.

Hemostemix Closes $360,000 First Tranche of Private Placement

Calgary, Alberta--(Newsfile Corp. - June 26, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF...

Hemostemix' $1,000,000 Private Placement and Update

Calgary, Alberta--(Newsfile Corp. - June 17, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is...

Hemostemix Leadership Attending Abundance360 Summit

Calgary, Alberta--(Newsfile Corp. - March 9, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0...

Hemostemix Appoints Renowned Vascular Surgeon and Principal Investigator, Dr. York Hsiang, as Business Consultant to Advance First Nations-Led Healthcare Partnerships

Calgary, Alberta--(Newsfile Corp. - February 3, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0...

Hemostemix Receives FDA Support for Its Basket Protocol Approach

Calgary, Alberta--(Newsfile Corp. - January 16, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0...

Hemostemix Closes $480,000 Private Placement at $0.12 per Share

Calgary, Alberta--(Newsfile Corp. - December 31, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0...

Hemostemix Appoints Dr. David B. Alper, to Lead Multidisciplinary Physician Education in the Use of ACP-01

Calgary, Alberta--(Newsfile Corp. - December 23, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0...

Hemostemix CEO Introduces Conformal Consciousness Hypothesis A = E/(hv)

Thomas Smeenk, BA, unveils a proposed conformal invariant, A = E/(hv), explored as a potential bridge between...

Hemostemix Grants Stock Options

Calgary, Alberta--(Newsfile Corp. - December 11, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0...

Hemostemix Inc. Announces FDA Pre-IND Meeting and NBPP of $960,000

Calgary, Alberta--(Newsfile Corp. - December 10, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

HEM - Frequently Asked Questions (FAQ)

What is the current Hemostemix Inc share price?

The current share price of Hemostemix Inc is $ 0,055

How many Hemostemix Inc shares are in issue?

Hemostemix Inc has 197 821 441 shares in issue

What is the market cap of Hemostemix Inc?

The market capitalisation of Hemostemix Inc is CAD 10,88M

What is the 1 year trading range for Hemostemix Inc share price?

Hemostemix Inc has traded in the range of $ 0,00 to $ 0,00 during the past year

What is the PE ratio of Hemostemix Inc?

The price to earnings ratio of Hemostemix Inc is -2,35

What is the registered address of Hemostemix Inc?

The registered address for Hemostemix Inc is 707-7th Avenue SW, Calgary, Alberta, T2P 3H6

What is the Hemostemix Inc website address?

The website address for Hemostemix Inc is hemostemix.com

Which industry sector does Hemostemix Inc operate in?

Hemostemix Inc operates in the Biotechnology & Life Sciences sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Grayscale Livepeer (QB)

Farmers and Merchants Ba... (QX)

Bank of Queensland

Splash Beverage

Barkly Rare Earths

Amundi Stoxx EU Technology

WisdomTree International...

Jarvis Securities

Johnson And Johnson

State Street Real Estate...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

ADVFN

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.